EMA starts review of dexamethasone for treating adults with COVID-19 requiring respiratory support

The EMA is reviewing results from the RECOVERY study arm that involved the use of dexamethasone for patients with COVID-19 admitted to hospital. It aims to provide an opinion on the results, and in particular the potential use of dexamethasone for adults with COVID-19.


European Medicines Agency